Management of primary anorectal mucosal melanoma during the COVID-19 pandemic

Yan-Quiroz E.F.; Agreda-Castro F.M.; Diaz-Lozano L.; Tenazoa-Villalobos R.; Fernández-Rodríguez L.J. · ecancermedicalscience (2023) · DOI: 10.3332/ecancer.2023.1610

Resumen

Anorectal melanoma is a rare and difficult-to-diagnose highly malignant cancer with a poor prognosis. The treatment usually involves surgery and often includes adjuvants such as radiation therapy and immunotherapy. We present a case of a 77-year-old Peruvian who was eventually diagnosed with this cancer during the COVID-19 pandemic, which complicated her treatment and allowed the cancer to spread. Her treatment included abdominoperineal resection, bilateral pelvic lymphadenectomy, left internal iliac vein raffia and end colostomy, followed by 3D radiation therapy (50 Gy, 25 sessions) and systemic treatment with nivolumab, all of which were well tolerated. The patient was alive as of 20 August 2023, having survived for more than 3 years since the onset of symptoms.

Instituciones: Universidad Privada Antenor Orrego